Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity
Year: 2024
Type: article
Abstract: Given the global surge in autoimmune diseases, it is critical to evaluate emerging therapeutic interventions. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and evaluate the effects of these treatments longitudinally are lacking. Here, we leveraged advances in programmable-phage immunoprecipitation methodology to explore the modulation, or lack thereof, of autoantibody profiles, proteome-wide, in both health and disease. Using a custom set of over 730,000 human-derived peptides, we demonstrated that each individual, regardless of disease state, possesses a distinct and complex constellation of autoreactive antibodies. For each individual, the set of resulting autoreactivites constituted a unique immunological fingerprint, or "autoreactome," that was remarkably stable over years. Using the autoreactome as a primary output, we evaluated the relative effectiveness of various immunomodulatory therapies in altering autoantibody repertoires. We found that therapies targeting B cell maturation antigen (BCMA) profoundly altered an individual's autoreactome, while anti-CD19 and anti-CD20 therapies had minimal effects. These data both confirm that the autoreactome comprises autoantibodies secreted by plasma cells and strongly suggest that BCMA or other plasma cell-targeting therapies may be highly effective in treating currently refractory autoantibody-mediated diseases.
DOI: 10.1172/jci180012
Authors: Aaron Bodansky, David J.L. Yu, Alysa Rallistan, Muge Kalaycioglu, Jim Boonyaratanakornkit, Damian J. Green, Jordan Gauthier, Cameron J. Turtle, Kelsey Zorn, Brian O’Donovan, Caleigh Mandel-Brehm, James Asaki, Hannah Kortbawi, Andrew F. Kung, Elze Rackaityte, Chung-Yu Wang, Aditi Saxena, Kimberly de Dios, Gianvito Masi, Richard J. Nowak, Kevin C. O’Connor, Hao Li, Valentina E. Diaz, Rowan Saloner, Kaitlin B. Casaletto, Eva Q. Gontrum, Brandon Chan, Joel H. Kramer, Michael R. Wilson, Paul J. Utz, Joshua A. Hill, Shaun W. Jackson, Mark S. Anderson, Joseph L. DeRisi
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,200
Funders: Larry L. Hillblom Foundation, Amgen, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Gilead Sciences, Alexion Pharmaceuticals, Celgene, Angiocrine Bioscience, Rare Diseases Clinical Research Network, Argenx, Springworks Therapeutics, Swedish Orphan Biovitrum, MorphoSys, National Institutes of Health, Centers for Disease Control and Prevention, Genentech, University of California, San Francisco, Kite Pharma, Juno Therapeutics, Legend Biotech, National Institute on Aging, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Child Health and Human Development, Janssen Biotech, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Eurostars
Awards: G1253688923, G1275810520, G1636177350, Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study, G2051510764, G33247875, G3333209551, G3426671974, G4279768677, G5288657676, G5514976981, G6570754590, Biological predictors of brain aging trajectories, Novel Approaches for Investigating the Pathology of Myasthenia Gravis Autoantibodies, B cell costimulatory signals in the pathogenesis of SLE, Molecular determinants driving diverse mechanisms of antibody-mediated pathology, G89556848, G9000003965, G9000054626, Medical Scientist Training Program (T32 NRSA Training Grant), Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE, Rare Disease Network for Myasthenia Gravis, New Approaches to Dementia Heterogeneity, Pediatric Scientist Development Program, Predoctoral Training in Biomedical Sciences, Data Management and Coordinating Center: Rare Diseases Clinical Research Network, Biological predictors of brain aging trajectories, Yale Clinical and Translational Science Award, Unraveling the intersection of synaptic biology, lifestyle, and cognitive resilience, Mechanisms of autoimmunity in myasthenia gravis
OpenAlex ID: W4398155824
